Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review.

Objectives The aim of this systematic literature review was to summarize the current knowledge regarding the prevalence of, time to recovery from, and influence of glucocorticoid dose and duration on glucocorticoid-induced adrenal insufficiency (AI). Methods Eligible studies were original research a...

Descripción completa

Detalles Bibliográficos
Publicado en:Seminars in Arthritis & Rheumatism Vol. 46; no. 1; pp. 133 - 142
Autores principales: Joseph, Rebecca M., Hunter, Ann Louise, Ray, David W., Dixon, William G.
Formato: research systematic review Journal Article
Publicado: W B Saunders Aug2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=121784377&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 121784377
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00490172
        4GQ
      jtl: Seminars in Arthritis & Rheumatism
      issn: 00490172
      maglogo: N
    pubinfo:
      dt: Aug2016
      vid: 46
      iid: 1
      pid: 1351
      pub: W B Saunders
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        121784377
        121784377
        121784377
        10.1016/j.semarthrit.2016.03.001
        121784377
      ppf: 133
      ppct: 9
      formats:
      tig:
        atl: Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review.
      aug:
        au:
          Joseph, Rebecca M.
          Hunter, Ann Louise
          Ray, David W.
          Dixon, William G.
        affil: NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK
      sug:
        subj:
          Glucocorticoids Therapeutic Use
          Adrenal Insufficiency Chemically Induced
          Glucocorticoids Adverse Effects
          Adult
          Human
          Prednisolone
          Prevalence
          Systematic Review
          Medline
          Adrenal Glands Physiology
          Glucocorticoids Administration and Dosage
          Bias (Research)
          Prednisolone Administration and Dosage
          Adrenal Insufficiency Prevention and Control
          Adult: 19-44 years
      ab: Objectives The aim of this systematic literature review was to summarize the current knowledge regarding the prevalence of, time to recovery from, and influence of glucocorticoid dose and duration on glucocorticoid-induced adrenal insufficiency (AI). Methods Eligible studies were original research articles, which included adult patients with an indication for glucocorticoids and measured adrenal function following exposure to systemic glucocorticoids. Searches were performed in Web of Science and MEDLINE, with further articles identified from reference lists. Screening was performed in duplicate. Data were extracted for each group of glucocorticoid-exposed patients within eligible studies. The reported proportion of patients with AI was summarized as median and inter-quartile range. Results were then stratified by daily dose, cumulative dose, duration of exposure and time since last glucocorticoid use. The risk of bias within and across studies was considered: for randomised controlled trials risk of bias was assessed using the tool developed by the Cochrane Collaboration. Results Overall, 73 eligible studies were identified out of 673 screened. The percentage of patients with AI ranged from 0% to 100% with a median (IQR) = 37.4% (13–63%). Studies were small—median (IQR) group size 16 (9–38)—and heterogeneous in methodology. AI persisted in 15% of patients retested 3 years after glucocorticoid withdrawal. Results remained widely distributed following stratification. AI was demonstrated at <5 mg prednisolone equivalent dose/day, <4 weeks of exposure, cumulative dose <0.5 g, and following tapered withdrawal. Conclusions The heterogeneity of studies and variability in results make it difficult to answer the research questions with confidence based on the current literature. There is evidence of AI following low doses and short durations of glucocorticoids. Hence, clinicians should be vigilant for adrenal insufficiency at all degrees of glucocorticoid exposure.
      pubtype: Academic Journal
      doctype:
        research
        systematic review
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N